MedPath

A Comparison of Injection Pain of Propofol During Endoscopy : LCT Propofol vs MCT/LCT Propofol

Phase 4
Completed
Conditions
Pain
Complication of Injection
Interventions
Drug: Fresofol
Drug: Propofol
Registration Number
NCT02567916
Lead Sponsor
Kyungpook National University Hospital
Brief Summary

The purpose of this study is to compare the incidence and intensity of possible pain on injection as well as patient satisfaction caused by long chain triglyceride propofol versus medium/long chain combinated triglyceride propofol on endoscopy.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
129
Inclusion Criteria
  • age >15 yrs
  • ASA (American Society of Anesthesiologists risk class III-IV)I-II
  • patients undergoing to gastroscopy
Read More
Exclusion Criteria
  • significant systemic disease (American Society of Anesthesiologists risk class III-IV)
  • history of allergic reactions to any of the study drugs
  • chronic use of opioid analgesics
  • psychiatric disorder
  • arrythmia
  • pregnancy
  • age <18 yrs
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
FRESOFOL MCTFresofolTo compare the incidence and intensity of pain on injection that is caused by propofol (LCT propofol) versus fresofol (MCT/LCT propofol) .
PropofolPropofolThe purpose of this study is to compare the incidence and intensity of possible pain on injection as well as patient satisfaction caused by propofol (LCT propofol) versus fresofol (MCT/LCT propofol).
Primary Outcome Measures
NameTimeMethod
Incidence and Intensity of Pain on Injection That is Caused by Propofol (LCT propofol) Versus the Fresofol (MCT/LCT propofol).2 hours
Secondary Outcome Measures
NameTimeMethod
Patient Satisfaction With Sedation Including the Recall of Pain.2 hours and 5-7days after the end of the procedure

Trial Locations

Locations (1)

Keimyung University Dongsan Medical Center

🇰🇷

Daegu, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath